|
JKAMP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.135100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.604300E-04 |
| Normal-vs-Stage2 |
2.954000E-01 |
| Normal-vs-Stage3 |
8.197600E-01 |
| Normal-vs-Stage4 |
3.722600E-01 |
| Stage1-vs-Stage2 |
3.024800E-01 |
| Stage1-vs-Stage3 |
2.842100E-02 |
| Stage1-vs-Stage4 |
5.487200E-01 |
| Stage2-vs-Stage3 |
4.983600E-01 |
| Stage2-vs-Stage4 |
8.939000E-01 |
| Stage3-vs-Stage4 |
5.050800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.860800E-03 |
| Normal-vs-AfricanAmerican |
3.882000E-02 |
| Normal-vs-Asian |
8.369400E-01 |
| Caucasian-vs-AfricanAmerican |
7.450200E-01 |
| Caucasian-vs-Asian |
5.119600E-01 |
| AfricanAmerican-vs-Asian |
6.208400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.182060E-03 |
| Normal-vs-Female |
1.446370E-01 |
| Male-vs-Female |
1.412190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.071700E-02 |
| Normal-vs-Extreme_Weight |
7.438500E-04 |
| Normal-vs-Obese |
9.338200E-02 |
| Normal-vs-Extreme_Obese |
2.638300E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.488400E-01 |
| Normal_Weight-vs-Obese |
5.515600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.557400E-01 |
| Extreme_Weight-vs-Obese |
1.646570E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.752800E-01 |
| Obese-vs-Extreme_Obese |
4.268600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.698200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.798500E-02 |
| Normal-vs-Age(61-80Yrs) |
6.418200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.974500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.358000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.157350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.169000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.793900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.095600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.084200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.382900E-03 |
| Normal-VS-Type2 PRCC |
5.701800E-02 |
| Normal-VS-KIRP CIMP |
9.381600E-01 |
| Normal-VS-Unclassified PRCC |
1.571560E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.050800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.105600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.846000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.279800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.778400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.928200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.101100E-03 |
| Normal-vs-N1 |
8.449400E-01 |
| Normal-vs-N2 |
1.450030E-02 |
| N0-vs-N1 |
4.097700E-02 |
| N0-vs-N2 |
4.803000E-01 |
| N1-vs-N2 |
1.422230E-01 |
|
|
